Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4+ T cells

European Journal of Immunology

Volumn 43, Issue 10, 2013, Pages 2730-2740

  Corre, Béatrice ^a   Perrier, Julie ^a   El Khouri, Margueritte ^a   Cerboni, Silvia ^a   Pellegrini, Sandra ^a   Michel, Frédérique ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

CD4+ T cells; IFN ; IL 10; T helper cells; Tr1 cells

Indexed keywords

ALPHA INTERFERON; CD28 ANTIGEN; CD45RA ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; T LYMPHOCYTE RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

CD4+ T CELLS; IFN-Α/Β; IL-10; T HELPER CELLS; TR1 CELLS;

ANTIGENS, CD28; ANTIGENS, CD45; CELL DIFFERENTIATION; CELLS, CULTURED; FEEDBACK, PHYSIOLOGICAL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; PROTEIN BINDING; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84885783510     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242977     Document Type: Article

References (55)

1. Lienenklaus, S., Cornitescu, M., Zietara, N., Lyszkiewicz, M., Gekara, N., Jablonska, J., Edenhofer, F. et al., Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J. Immunol. 2009. 183: 3229-3236.
2. Gough, D. J., Messina, N. L., Clarke, C. J., Johnstone, R. W. and Levy, D. E., Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 2012. 36: 166-174.
3. Swiecki, M. and Colonna, M., Type I interferons: diversity of sources, production pathways and effects on immune responses. Curr. Opin. Virol. 2011. 1: 463-475.
4. Cohen, J. A., Barkhof, F., Comi, G., Hartung, H. P., Khatri, B. O., Montalban, X., Pelletier, J. et al., Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 2010. 362: 402-415.
5. Sospedra, M. and Martin, R., Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005. 23: 683-747.
6. Blanco, P., Palucka, A. K., Gill, M., Pascual, V. and Banchereau, J., Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001. 294: 1540-1543.
7. Ronnblom, L., Alm, G. V. and Eloranta, M. L., The type I interferon system in the development of lupus. Semin. Immunol. 2011. 23: 113-121.
8. Santini, S. M., Lapenta, C., Santodonato, L., D'Agostino, G., Belardelli, F. and Ferrantini, M., IFN-alpha in the generation of dendritic cells for cancer immunotherapy. Handb. Exp. Pharmacol. 2009: 295-317.
9. Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H. et al., Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 2011. 208: 1989-2003.
10. Fuertes, M. B., Kacha, A. K., Kline, J., Woo, S. R., Kranz, D. M., Murphy, K. M. and Gajewski, T. F., Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J. Exp. Med. 2011. 208: 2005-2016.
11. Beuneu, H., Deguine, J., Bouvier, I., Di Santo, J. P., Albert, M. L. and Bousso, P., Cutting Edge: A dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation. J. Immunol. 2011. 187: 2084-2088.
12. Dondi, E., Roue, G., Yuste, V. J., Susin, S. A. and Pellegrini, S., A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response. J. Immunol. 2004. 173: 3740-3747.
13. Huber, J. P. and Farrar, J. D., Regulation of effector and memory T-cell functions by type I interferon. Immunology 2011. 132: 466-474.
14. Brinkmann, V., Geiger, T., Alkan, S. and Heusser, C. H., Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J. Exp. Med. 1993. 178: 1655-1663.
15. Letimier, F. A., Passini, N., Gasparian, S., Bianchi, E. and Rogge, L., Chromatin remodeling by the SWI/SNF-like BAF complex and STAT4 activation synergistically -12induce IL-12Rbeta2 expression during human Th1 cell differentiation. EMBO J. 2007. 26: 1292-1302.
16. McRae, B. L., Semnani, R. T., Hayes, M. P. and van Seventer, G. A., Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 1998. 160: 4298-4304.
17. Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R. and Roncarolo, M. G., IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 2001. 166: 5530-5539.
18. Ramos, H. J., Davis, A. M., George, T. C. and Farrar, J. D., IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression. J. Immunol. 2007. 179: 3792-3803.
19. Axtell, R. C., de Jong, B. A., Boniface, K., van der Voort, L. F., Bhat, R., De Sarno, P., Naves, R. et al., T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010. 16: 406-412.
20. Parronchi, P., De Carli, M., Manetti, R., Simonelli, C., Sampognaro, S., Piccinni, M. P., Macchia, D. et al., IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 1992. 149: 2977-2983.
21. Huber, J. P., Ramos, H. J., Gill, M. A. and Farrar, J. D., Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J. Immunol. 2010. 185: 813-817.
22. Ramgolam, V. S., Sha, Y., Jin, J., Zhang, X. and Markovic-Plese, S., IFN-beta inhibits human Th17 cell differentiation. J. Immunol. 2009. 183: 5418-5427.
23. Sweeney, C. M., Lonergan, R., Basdeo, S. A., Kinsella, K., Dungan, L. S., Higgins, S. C., Kelly, P. J. et al., IL-27 mediates the response to IFN-beta therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav. Immun. 2011. 25: 1170-1181.
24. Aman, M. J., Tretter, T., Eisenbeis, I., Bug, G., Decker, T., Aulitzky, W. E., Tilg, H. et al., Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood 1996. 87: 4731-4736.
25. Iyer, S. S., Ghaffari, A. A. and Cheng, G., Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J. Immunol. 2010. 185: 6599-6607.
26. Swiecki, M., Wang, Y., Vermi, W., Gilfillan, S., Schreiber, R. D. and Colonna, M., Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J. Exp. Med. 2011. 208: 2367-2374.
27. Fuertes Marraco, S. A., Scott, C. L., Bouillet, P., Ives, A., Masina, S., Vremec, D., Jansen, E. S. et al., Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS One 2011. 6: e20189.
28. Le Buanec, H., Gougeon, M. L., Mathian, A., Lebon, P., Dupont, J. M., Peltre, G., Hemon, P. et al., IFN-alpha and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells. Proc. Natl. Acad. Sci. USA 2011. 108: 18995-19000.
29. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. and Roncarolo, M. G., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737-742.
30. Vieira, P. L., Christensen, J. R., Minaee, S., O'Neill, E. J., Barrat, F. J., Boonstra, A., Barthlott, T. et al., IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 2004. 172: 5986-5993.
31. O'Garra, A. and Vieira, P., T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 2007. 7: 425-428.
32. Gabrysova, L., Nicolson, K. S., Streeter, H. B., Verhagen, J., Sabatos-Peyton, C. A., Morgan, D. J. and Wraith, D. C., Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J. Exp. Med. 2009. 206: 1755-1767.
33. Cope, A., Le Friec, G., Cardone, J. and Kemper, C., The Th1 life cycle: molecular control of IFN-gamma to IL-10 switching. Trends Immunol. 2011. 32: 278-286.
34. Acuto, O. and Michel, F., CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 2003. 3: 939-951.
35. Acuto, O., Di Bartolo, V. and Michel, F., Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat. Rev. Immunol. 2008. 8: 699-712.
36. Zhu, J., Yamane, H. and Paul, W. E., Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 2010. 28: 445-489.
37. Viola, A. and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds. Science 1996. 273: 104-106.
38. Manickasingham, S. P., Anderton, S. M., Burkhart, C. and Wraith, D. C., Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro. J. Immunol. 1998. 161: 3827-3835.
39. Saraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M. and O'Garra, A., Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009. 31: 209-219.
40. Walker, M. R., Kasprowicz, D. J., Gersuk, V. H., Benard, A., Van Landeghen, M., Buckner, J. H. and Ziegler, S. F., Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 2003. 112: 1437-1443.
41. Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grutzkau, A., Dong, J., Thiel, A. et al., DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 2007. 37: 2378-2389.
42. Michel, F., Attal-Bonnefoy, G., Mangino, G., Mise-Omata, S. and Acuto, O., CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 2001. 15: 935-945.
43. Haringer, B., Lozza, L., Steckel, B. and Geginat, J., Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J. Exp. Med. 2009. 206: 1009-1017.
44. Rivino, L., Gruarin, P., Haringer, B., Steinfelder, S., Lozza, L., Steckel, B., Weick, A. et al., CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function. J. Exp. Med. 2010. 207: 565-577.
45. Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S. et al., Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 2012. 484: 514-518.
46. Gabrysova, L., Christensen, J. R., Wu, X., Kissenpfennig, A., Malissen, B. and O'Garra, A., Integrated T-cell receptor and costimulatory signals determine TGF-beta-dependent differentiation and maintenance of Foxp3+ regulatory T cells. Eur. J. Immunol. 2011. 41: 1242-1248.
47. Walker, M. R., Carson, B. D., Nepom, G. T., Ziegler, S. F. and Buckner, J. H., De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc. Natl. Acad. Sci. USA 2005. 102: 4103-4108.
48. Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H. and Kronenberg, M., Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 2009. 10: 1178-1184.
49. Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J. M., Jack, R. S. et al., Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011. 34: 566-578.
50. Naundorf, S., Schroder, M., Hoflich, C., Suman, N., Volk, H. D. and Grutz, G., IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells. Eur. J. Immunol. 2009. 39: 1066-1077.
51. Ozenci, V., Kouwenhoven, M., Huang, Y. M., Xiao, B., Kivisakk, P., Fredrikson, S. and Link, H., Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment. Scand. J. Immunol. 1999. 49: 554-561.
52. Chatenoud, L. and Bluestone, J. A., CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 2007. 7: 622-632.
53. Weiner, H. L., da Cunha, A. P., Quintana, F. and Wu, H., Oral tolerance. Immunol. Rev. 2011. 241: 241-259.
54. Esplugues, E., Huber, S., Gagliani, N., Hauser, A. E., Town, T., Wan, Y. Y., O'Connor, W., Jr. et al., Control of TH17 cells occurs in the small intestine. Nature 2011. 475: 514-518.
55. Huber, S., Gagliani, N., Esplugues, E., O'Connor, W., Jr., Huber, F. J., Chaudhry, A., Kamanaka, M. et al., Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3 +regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 2011. 34: 554-565.